INNOVATORS

Lilly and Abbisko Join Forces to Accelerate the Future of Drug Discovery

PBO Admin -
The new research collaboration aims to combine scientific expertise and advanced discovery platforms to...

Premier Health Charts a Path Through Compliance Challenges

PBO Admin -
Canadian Healthtech Company Works to Complete Financial Filings While Maintaining Focus on Digital Healthcare...

Drug Discovery 2026 Gathers Scientific Leaders for Landmark London Conference

Pharma Outlook -
ELRIG reveals keynote speakers as the industry prepares to explore the next generation of...

FDA Explores Artificial Intelligence to Strengthen Drug Safety Testing

Pharma Outlook -
New initiative highlights how AI is helping transform pharmaceutical research and accelerate the development...

Combination Therapy Shows Promise for Better Allergy Relief

Pharma Outlook -
A growing body of research suggests that combining montelukast and bilastine may...

AI Powers the Next Wave of Drug Discovery as Bristol Myers Squibb Expands NVIDIA Partnership

PBO Admin -
A stronger collaboration between Bristol Myers Squibb and NVIDIA aims to speed...

Expanding Care Closer to Home as NYU Langone Strengthens South Florida Network

Pharma Outlook -
New physician practices in Palm Beach County are bringing more specialty healthcare...

AI-Designed Lung Disease Drug Reaches Major Milestone with Phase III Trial

Pharma Outlook -
Insilico Medicine moves its AI-discovered treatment for idiopathic pulmonary fibrosis into late-stage...

Magazines

Pharmacy Management

Press release

Pharmaceutical Packaging Summit 2026 San Diego, CA

Pharma Outlook -
The Pharmaceutical Packaging Summit 2026 will take place on the 5-6 October 2026 at the Park Hyatt Aviara Resort, Golf Club & Spa, San Diego, CA, bringing...
Clinical Trial Management

Combination Therapy Shows Promise for Better Allergy Relief

Pharma Outlook -
A growing body of research suggests that combining montelukast and bilastine may improve symptom control for people with allergic rhinitis while maintaining a favorable safety profile Boston, Massachusetts,...
Press release

Marcus Evans Announces the Medical Device Manufacturing & R&D Summit 2026

Pharma Outlook -
Senior MedTech Executives to Convene in San Diego for Two Days of Strategic Dialogue and Industry Intelligence San Diego, CA | November 2–3, 2026 Marcus Evans, the global business...
Drug Discovery and Development

AI Powers the Next Wave of Drug Discovery as Bristol Myers Squibb Expands NVIDIA Partnership

PBO Admin -
A stronger collaboration between Bristol Myers Squibb and NVIDIA aims to speed up medicine development using advanced artificial intelligence and powerful computing technology Princeton, New Jersey, 22 July...
Load more

Clinical Trial Management

Clinical Trial Management

Combination Therapy Shows Promise for Better Allergy Relief

A growing body of research suggests that combining montelukast and bilastine may improve symptom control for people with allergic rhinitis while maintaining a favorable safety profile Boston, Massachusetts,...
Clinical Trial Management

Premier Health Charts a Path Through Compliance Challenges

Canadian Healthtech Company Works to Complete Financial Filings While Maintaining Focus on Digital Healthcare Innovation Montreal, Quebec, 18 June 2026 – Premier Health of America is navigating a...
Clinical Trial Management

AI in Clinical Trials Faces New Pressure Over Real-Time Safety and Data Accuracy

As artificial intelligence becomes more common in clinical research, experts warn that maintaining data quality and patient safety is becoming increasingly complex Boston, Massachusetts, 21 May 2026 –...
Clinical Trial Management

J&J’s Heart Pump Study Offers New Hope for High-Risk Cardiac Surgery Patients

Pilot study reveals promising results for planned Impella 5.5 support in complex heart surgeries. Chicago, Illinois, 7 May 2026 – Johnson & Johnson has announced encouraging results from...
Clinical Trial Management

New trial shows embolization sharply lowers risk in mild subdural hematoma

EMBOLISE-2 finds early artery-blocking treatment cuts deterioration and surgery needs by half Los Angeles, United States, 10 February 2026 – A minimally invasive procedure known as middle meningeal...